Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I agree! great read, great outlook. I am waiting for financials to be published before topping up...
I know nothing of this company but that RNS has to be very very good news doesit not?
GL.
Apologies, working link here: https://www.equitydevelopment.co.uk/research/growth-drivers-aligned-with-aquaculture-sustainability-goals
Our fair value per share of 88p represents a near 50% premium to the current price https://equitydevelopment.co.uk/research/growth-drivers-aligned-with-aquaculture-sustainability-goals
Trond Williksen, CEO, and Septima Maguire, CFO, run through their results, the progress they are making on the route to commercialising BMK08 and CleanTreat, and how the journey to cash flow break even is progressing. https://youtu.be/gis0NXxc5RE
Lots to like here - Director buys + Clean treat authorisation to come = re-rate + Equity announcing target 88 but most of all, I can’t find competition here. Aquaculture is so bespoke
Company acknowledge Brexit delays which will be managed
Please listen to the videos available on chat links below, Trond makes a very telling comment at the end - “they need us”. Yes, the fishing industry does.
Confess I don’t understand the SP fall today but see this as a solid buy going beyond Equity’s target
https://www.equitydevelopment.co.uk/research/well-set-ahead-of-key-product-launches
BMK is seeing the rewards from its focus on aquaculture and a tighter cost base; continuing operations delivered Q1 2021 revenue growth of 18% to £29m, vs Q1 2020. When coupled with cost containment this provided an impressive 7.5x increase in EBITDA. This places BMK in a strong position to execute the next phase of the strategic drive to profitability through product launches and growth initiatives. Visibility is improving in Advanced Nutrition, along with early signs of recovery in some shrimp markets, solid performance in Genetics and a reduced loss in the newly restructured Health division. BMK’s prospects are improving along with momentum from new product launches. We upgrade our FY2021-23 forecasts leading to a net profit of £15.4m in FY 2023.
The Group is seeing strategic focus pay off. With encouraging signs of recovery, BMK can leverage its central position in global aquaculture markets to support the launch of innovative products. As such, we increase our share price value to 88p per share from 72p. Grant of BMK08 + CleanTreat®? Marketing Authorisation will provide further rerating potential.
Trond Williksen, CEO, and Septima Maguire, CFO, discuss the path forward with a successful restructuring behind them, the Q2 launch of BMK08 CleanTreat, and the resilience of the salmon market throughout the pandemic.
https://youtu.be/sWP8mkFkLC0
https://zoom.us/webinar/register/8916135599097/WN_DPuJTbmDTbihSCLBZ5DUKw
Benchmark Holdings plc (AIM: BMK), the aquaculture health, advanced nutrition, and genetics business, will be conducting a presentation covering its Q1 Results for the quarter ended 31st December 2020. The presentation will be hosted by Trond Williksen, Chief Executive Officer, and Septima Maguire, Chief Financial Officer.
The event will take place at 12.00pm on Monday 22nd February 2021.
The online presentation is open to all existing and potential shareholders. Questions can be submitted during the presentation to be addressed at the end.
Looks to me like good insider support recently.
... that went up to 55.45 million. Whoever bought that block must be comfortable with the Company's outlook.
There have been some big share lots going through over the last Month or two, including 46,6 million today. Somebody must have some confidence in this Company.
Cuz government in need for such facilities, if they don’t make it useful much better to sell it. I see that a good deal
Very good deal
What's left? As far as I am concerned, the Vaccine Business was one of the most exciting parts of Benchmark, This looks to me like a bad move!
Massive update
Peter is a very clever man
Look what he done at Clinigen
Peter George buying shares, looking to turn this company around. I'm very interested in investing here.
Horrible, horrible results, and it looks like the Coronavirus will impact them as well. Sorry LO, but I'd still sell if I were you.
Hey LO - sorry, didn't see your post till now. I genuinely hope you make your money back on this, but as I said below, just one kick in the groin too many for me. Fortunately, my position wasn't so big as to make the loss very painful, but another one to chalk up to experience!!
Hey Matt - long time since we met on here. Totally agree, but as said before I am sooooo deep into this one that I really have to sit it out. Have been drawn in 3 times on the early placings, and like many am now a bit stuck with it waiting for that jam.
At least this year they have got rid of the Pye / Pamplin axis of doom - I still remember meeting with those two jokers 5 years ago and grilling them about why with every acquisition or step forward they appointed another 5 directors.....Classic big brains who could develop a start-up but just couldn't understand how to scale up and move this from being an zoo-ologist's hobby to a proper business.
So it finishes the year strongly at the bottom of my portfolio with a massive underwater position (oh the irony of an acquaculture business being underwater!) and I thought getting caught with XLM and WPCT/SUPP was a bad end to the year - but those losses pale in comparision to this dog.
Bugger.....
I'm out. Always jam tomorow and a pile of garbage today. Shame on them.